This might be one of the reasons for drug resistance of BCL2 inhibitors, and it was worth further exploring the underlying mechanism of drug resistance mediated by TSC22D3.c-Fos has been reported to play crucial parts in the maintenance and proliferation of AML [34]. This evidence concerns the gene BCL2 and acute myeloid leukemia.